BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29953536)

  • 1. Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study.
    Kang JH; Kao LT; Lin HC; Wang TJ; Yang TY
    PLoS One; 2018; 13(6):e0199981. PubMed ID: 29953536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection.
    Erlandson KM; Kitch D; Wester CW; Kalayjian RC; Overton ET; Castillo-Mancilla J; Koletar SL; Benson CA; Campbell TB; Robertson K; Lok JJ
    Clin Infect Dis; 2017 Nov; 65(12):2042-2049. PubMed ID: 29020174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents.
    De Spiegeleer A; Bronselaer A; Teo JT; Byttebier G; De Tré G; Belmans L; Dobson R; Wynendaele E; Van De Wiele C; Vandaele F; Van Dijck D; Bean D; Fedson D; De Spiegeleer B
    J Am Med Dir Assoc; 2020 Jul; 21(7):909-914.e2. PubMed ID: 32674818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
    Majd Z; Mohan A; Paranjpe R; Abughosh SM
    J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and community-acquired pneumonia: A nationwide population propensity-score matching study.
    Lin SY; Chang SS; Lin CL; Lin CC; Hsu WH; Chou CH; Chi CY; Lin CD; Tu CY; Hsu CY; Kao CH
    Int J Clin Pract; 2021 Oct; 75(10):e14476. PubMed ID: 34107133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts.
    Cardwell CR; Mc Menamin ÚC; Hicks BM; Hughes C; Cantwell MM; Murray LJ
    BMC Med; 2014 Feb; 12():28. PubMed ID: 24521426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.
    Zhang P; Zhu L; Cai J; Lei F; Qin JJ; Xie J; Liu YM; Zhao YC; Huang X; Lin L; Xia M; Chen MM; Cheng X; Zhang X; Guo D; Peng Y; Ji YX; Chen J; She ZG; Wang Y; Xu Q; Tan R; Wang H; Lin J; Luo P; Fu S; Cai H; Ye P; Xiao B; Mao W; Liu L; Yan Y; Liu M; Chen M; Zhang XJ; Wang X; Touyz RM; Xia J; Zhang BH; Huang X; Yuan Y; Loomba R; Liu PP; Li H
    Circ Res; 2020 Jun; 126(12):1671-1681. PubMed ID: 32302265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.
    Barthold D; Joyce G; Diaz Brinton R; Wharton W; Kehoe PG; Zissimopoulos J
    PLoS One; 2020; 15(3):e0229541. PubMed ID: 32130251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes.
    Mortensen EM; Nakashima B; Cornell J; Copeland LA; Pugh MJ; Anzueto A; Good C; Restrepo MI; Downs JR; Frei CR; Fine MJ
    Clin Infect Dis; 2012 Dec; 55(11):1466-73. PubMed ID: 22918991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.
    Hoang V; Alam M; Addison D; Macedo F; Virani S; Birnbaum Y
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):189-98. PubMed ID: 26861251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure.
    Sargento L; Simões AV; Longo S; Lousada N; Dos Reis RP
    Drugs Aging; 2016 Sep; 33(9):675-83. PubMed ID: 27568454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD.
    Lai CC; Wang YH; Wang CY; Wang HC; Yu CJ; Chen L
    Int J Chron Obstruct Pulmon Dis; 2018; 13():867-874. PubMed ID: 29563786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma and Non-Melanoma Skin Cancer Associated with Angiotensin-Converting-Enzyme Inhibitors, Angiotensin-Receptor Blockers and Thiazides: A Matched Cohort Study.
    Nardone B; Majewski S; Kim AS; Kiguradze T; Martinez-Escala EM; Friedland R; Amin A; Laumann AE; Edwards BJ; Rademaker AW; Martini MC; West DP
    Drug Saf; 2017 Mar; 40(3):249-255. PubMed ID: 27943160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies.
    Kunutsor SK; Blom AW; Whitehouse MR; Kehoe PG; Laukkanen JA
    Eur J Epidemiol; 2017 Nov; 32(11):947-959. PubMed ID: 28752198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy.
    Steely AM; Callas PW; Bertges DJ;
    J Vasc Surg; 2016 Mar; 63(3):715-21. PubMed ID: 26603543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers: New-onset diabetes mellitus stratified by statin use.
    Shin J; Kim H; Yim HW; Kim JH; Lee S; Kim HS
    J Clin Pharm Ther; 2022 Jan; 47(1):97-103. PubMed ID: 34668200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using group-based trajectory modeling to characterize the association of past ACEIs/ARBs adherence with subsequent statin adherence patterns among new statin users.
    Majd Z; Mohan A; Abughosh SM
    J Am Pharm Assoc (2003); 2021; 61(6):829-837.e2. PubMed ID: 34344613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
    Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
    Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-Angiotensin System Blockers and the Risk of COVID-19-Related Mortality in Patients with Kidney Failure.
    Soler MJ; Noordzij M; Abramowicz D; de Arriba G; Basile C; van Buren M; Covic A; Crespo M; Duivenvoorden R; Massy ZA; Ortiz A; Sanchez JE; Petridou E; Stevens K; White C; Vart P; Gansevoort RT;
    Clin J Am Soc Nephrol; 2021 Jul; 16(7):1061-1072. PubMed ID: 34088718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.